Literature DB >> 23149661

Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infection.

F J Ibarrondo1, S B Wilson, L E Hultin, R Shih, M A Hausner, P M Hultin, P A Anton, B D Jamieson, O O Yang.   

Abstract

Chronic inappropriate immune activation is the central defect-driving loss of CD4(+) T helper cells and progression to AIDS in persons with HIV-1 infection, but the mechanisms remain controversial. We examined key regulatory invariant receptor natural killer T (iNKT) cells in the gut, the largest reservoir of lymphocytes and a key arena of HIV-1 pathogenesis. In healthy control persons, the anti-inflammatory CD4(+) iNKT-cell subset predominated over the pro-inflammatory CD4(-) iNKT-cell subset in the gut, but not in the blood, compartment. HIV-1 infection resulted in a preferential loss of this anti-inflammatory CD4(+) iNKT-cell subset within the gut. The degree of loss of the CD4(+) iNKT-cell subset in the gut, but not in the blood, correlated to the systemic immune activation and exhaustion that have been linked to disease progression. These results suggest a potentially important contribution of gut iNKT-cell imbalance in determining the systemic immune activation that is the hallmark of HIV-1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23149661      PMCID: PMC3865278          DOI: 10.1038/mi.2012.101

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  50 in total

1.  Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue.

Authors:  P A Anton; J Elliott; M A Poles; I M McGowan; J Matud; L E Hultin; K Grovit-Ferbas; C R Mackay; J V Giorgi
Journal:  AIDS       Date:  2000-08-18       Impact factor: 4.177

2.  Natural killer T cells are targets for human immunodeficiency virus infection.

Authors:  Nadine Y Crowe; Dale I Godfrey; Alan G Baxter
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

3.  Gut microbes out of control in HIV infection.

Authors:  Barton F Haynes
Journal:  Nat Med       Date:  2006-12       Impact factor: 53.440

Review 4.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

5.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

Review 6.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

7.  A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.

Authors:  Jennifer E Snyder-Cappione; Camilla Tincati; Ijeoma G Eccles-James; Amedeo J Cappione; Lishomwa C Ndhlovu; Laura L Koth; Douglas F Nixon
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

8.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.

Authors:  Gabriel Bricard; Valerie Cesson; Estelle Devevre; Hanifa Bouzourene; Catherine Barbey; Nathalie Rufer; Jin S Im; Pedro M Alves; Olivier Martinet; Nermin Halkic; Jean-Charles Cerottini; Pedro Romero; Steven A Porcelli; H Robson Macdonald; Daniel E Speiser
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.

Authors:  Seddon Y Thomas; Runhua Hou; Jonathan E Boyson; Terry K Means; Christoph Hess; Douglas P Olson; Jack L Strominger; Michael B Brenner; Jenny E Gumperz; S Brian Wilson; Andrew D Luster
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

View more
  17 in total

1.  Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.

Authors:  Dominic Paquin-Proulx; Anna Gibbs; Susanna M Bächle; Antonio Checa; Andrea Introini; Edwin Leeansyah; Craig E Wheelock; Douglas F Nixon; Kristina Broliden; Annelie Tjernlund; Markus Moll; Johan K Sandberg
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

2.  Differential loss of invariant natural killer T cells and FoxP3⁺ regulatory T cells in HIV-1 subtype A and subtype D infections.

Authors:  Britta Flach; Prossy Naluyima; Kim Blom; Veronica D Gonzalez; Leigh Anne Eller; Oliver Laeyendecker; Thomas C Quinn; David Serwadda; Nelson K Sewankambo; Maria J Wawer; Ronald H Gray; Nelson L Michael; Fred Wabwire-Mangen; Merlin L Robb; Michael A Eller; Johan K Sandberg
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

3.  Seminal plasma HIV-1 RNA concentration is strongly associated with altered levels of seminal plasma interferon-γ, interleukin-17, and interleukin-5.

Authors:  Jennifer C Hoffman; Peter A Anton; Gayle Cocita Baldwin; Julie Elliott; Deborah Anisman-Posner; Karen Tanner; Tristan Grogan; David Elashoff; Catherine Sugar; Otto O Yang; Risa M Hoffman
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-02       Impact factor: 2.205

4.  Treatment-Naïve HIV-Infected Patients Have Fewer Gut-Homing β7 Memory CD4 T Cells than Healthy Controls.

Authors:  Nada Fadul; Jacob Couturier; Xiaoying Yu; Claudia Kozinetz; Roberto Arduino; Dorothy E Lewis
Journal:  South Med J       Date:  2017-11       Impact factor: 0.954

5.  Immunomodulation of antiretroviral drug-suppressed chronic HIV-1 infection in an oral probiotic double-blind placebo-controlled trial.

Authors:  Otto O Yang; Theodoros Kelesidis; Robert Cordova; Homayoon Khanlou
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-11       Impact factor: 1.723

Review 6.  Gut Innate Immunity and HIV Pathogenesis.

Authors:  Stephanie M Dillon; Cara C Wilson
Journal:  Curr HIV/AIDS Rep       Date:  2021-03-09       Impact factor: 5.495

7.  Exploring the feasibility of multi-site flow cytometric processing of gut associated lymphoid tissue with centralized data analysis for multi-site clinical trials.

Authors:  Ian McGowan; Peter A Anton; Julie Elliott; Ross D Cranston; Kathryn Duffill; Andrew D Althouse; Kevin L Hawkins; Stephen C De Rosa
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment.

Authors:  Camilla Tincati; Matteo Basilissi; Elisabetta Sinigaglia; Esther Merlini; Giovanni Carpani; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

9.  Natural killer T cells in advanced melanoma patients treated with tremelimumab.

Authors:  F Javier Ibarrondo; Otto O Yang; Thinle Chodon; Earl Avramis; Yohan Lee; Hooman Sazegar; Jason Jalil; Bartosz Chmielowski; Richard C Koya; Ingrid Schmid; Jesus Gomez-Navarro; Beth D Jamieson; Antoni Ribas; Begoña Comin-Anduix
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

10.  Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.

Authors:  D Paquin-Proulx; C Ching; I Vujkovic-Cvijin; D Fadrosh; L Loh; Y Huang; M Somsouk; S V Lynch; P W Hunt; D F Nixon; D SenGupta
Journal:  Mucosal Immunol       Date:  2016-04-06       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.